Research programme: estrogen receptor ligands - ENDECE
Alternative Names: NDC 1022; NDC 1352; NDC 1407Latest Information Update: 17 Feb 2020
At a glance
- Originator ENDECE
- Class Estradiol congeners; Small molecules
- Mechanism of Action Apoptosis stimulants; Estrogen receptor beta agonists; Estrogen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Multiple sclerosis
Highest Development Phases
- Discontinued Cancer; Inflammation; Pain
Most Recent Events
- 04 Feb 2020 Discontinued - Preclinical for Inflammation in USA (unspecified route)
- 04 Feb 2020 Discontinued - Preclinical for Pain in USA (unspecified route)
- 04 Feb 2020 Discontinued for Cancer in USA (IV)